Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

ESPEY MFG & ELECTRONICS CORP (ESP) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/09/2021 GN Espey Suspends Dividend
02/16/2021 GN Espey Mfg. & Electronics Corp. reports second quarter results
12/07/2020 GN Espey Declares Regular Quarterly Dividend of $0.25 Per Share
09/21/2020 GN Espey Mfg. & Electronics Corp. reports Fourth Quarter and Year-end results as well as Announces Regular Quarterly Dividend of $0.25 Per Share
06/08/2020 GN Espey Declares Regular Quarterly Dividend of $0.25 Per Share
03/09/2020 GN Espey Declares Regular Quarterly Dividend of $0.25 Per Share
02/13/2020 GN Espey Mfg. & Electronics Corp. reports record backlog and second quarter results
10/30/2019 GN ESPERITE (ESP) is not bankrupt
10/01/2019 GN Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
09/19/2019 GN CryoSave has maintained without compromise the high-quality processing and storage services and has handed over its whole business.
09/16/2019 GN Espey Mfg. & Electronics Corp. reports fourth quarter and year-end results
09/09/2019 GN Espey Declares Regular Quarterly Dividend of $0.25 Per Share
08/27/2019 GN ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE'S FAMILY STEM CELL BANKING BUSINESS
07/04/2019 GN Esperite N.V.: announces termination of audit engagement in relation to 2018 annual report
07/02/2019 GN ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
07/01/2019 GN ESPERITE NV (ESP) WITH CRYOSAVE CONFIRMS THE SAFETY OF ALL THE SAMPLES STORED AND THANKS THE 260'000 FAMILIES FOR THEIR TRUST AND CONFIDENCE.
07/01/2019 GN ESPERITE NV (ESP) MIT CRYOSAVE BESTÄTIGT DIE SICHERHEIT ALLER GELAGERTEN PROBEN UND DANKT DEN 260'000 FAMILIEN FÜR IHR VERTRAUEN.
07/01/2019 GN ESPERITE NV (ESP) CON CRYOSAVE CONFIRMA LA SEGURIDAD DE TODAS LAS MUESTRAS ALMACENADAS Y AGRADECE A LAS 260.000 FAMILIAS SU CONFIANZA.
07/01/2019 GN ESPERITE NV (ESP) AVEC CRYOSAVE CONFIRME LA SÉCURITÉ DE TOUS LES ÉCHANTILLONS STOCKÉS ET REMERCIE LES 260'000 FAMILLES POUR LEUR CONFIANCE.
07/01/2019 GN ESPERITE NV (ESP) CON CRYOSAVE CONFERMA LA SICUREZZA DI TUTTI I CAMPIONI CONSERVATI E RINGRAZIA LE 260'000 FAMIGLIE PER LA LORO FIDUCIA.
07/01/2019 GN ESPERITE NV (ESP) MET CRYOSAVE BEVESTIGT DE VEILIGHEID VAN ALLE OPGESLAGEN STALEN EN DANKT DE 260.000 FAMILIES VOOR HUN VERTROUWEN.
07/01/2019 GN ESPERITE NV (ESP) Z KRIOZAWA POTWIERDZA BEZPIECZENSTWO WSZYSTKICH PRZECHOWYWANYCH PRÓBEK I DZIEKUJE 260'000 RODZINOM ZA ICH ZAUFANIE I PEWNOSC SIEBIE.
07/01/2019 GN ESPERITE NV (ESP) COM CRYOSAVE CONFIRMA A SEGURANÇA DE TODAS AS AMOSTRAS ARMAZENADAS E AGRADECE ÀS 260.000 FAMÍLIAS PELA SUA CONFIANÇA.
07/01/2019 GN ESPERITE NV (?????????) ? CRYOSAVE ???????????? ???????????? ???? ?????????? ???????? ? ??????????? 260'000 ????? ?? ??????? ? ???????????.
07/01/2019 GN Az ESPERITE NV (ESP) CRYOSAVE-RÓL MEGBÍZHATÓ A MINDEN MINTABAN LÉTETT MINDEN BIZTONSÁGÁNAK ÉS K??SZÜLÉSE A HÍVÁSRA ÉS A MEGBÍZHATÓSÁGRA.
06/30/2019 GN ESPERITE N.V. (ESP) publishes its half-year report. Revenues, results and consolidated equity were impacted by adverse market conditions on the stem cell business.
06/28/2019 GN Esperite N.V.: Update to the market on the publication of the Annual Report 2018
06/14/2019 GN ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
06/13/2019 GN ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
06/10/2019 GN Espey Declares Regular Quarterly Dividend of $0.25 Per Share
06/04/2019 GN Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
06/04/2019 GN Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
05/29/2019 GN ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
05/19/2019 GN ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy